October 14, 2020/Ob/Gyn & Women’s Health

Long-acting Reversible Contraceptives for Adolescents

A toolkit for primary care physicians seeking to decrease unintended pregnancy in this population


Unintended pregnancy in adolescents remains a public health problem in the U.S. even during a global pandemic; as 64% of pregnancies in 20-24 year olds, 77% in 18-19 year olds and 90% in 15-17 year olds are unintended and/or unplanned.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

LARCs as first-line contraceptives

Teen pregnancy correlates with lower lifetime educational and economic achievement and a high likelihood of early parenting of their own offspring. Long-acting reversible contraceptives (LARCs) are recommended as the first-line, most effective contraceptive option according to the U.S. Centers for Disease Control and Prevention1 and the World Health Organization.2 Pediatricians often feel ill-equipped to counsel youth adequately on all options, and same-day LARC access can be a challenge. Thanks to a $645,753 grant from Merck, Ellen Rome, MD, MPH, will be doing research to create a toolkit usable by primary care clinicians to decrease unintended teen/young adult pregnancies through greater LARC use with easier access.

Dr. Rome and collaborators will use an evidence-based implementation framework to conduct interviews with pediatric practices that currently offer high-volume LARC services to identify the processes necessary for scaling up LARC delivery, including staffing needs, essential training on insertion/removal, billing, contracts, stocking and supply chain. This toolkit can then be used to scale up care locally and nationally.


  1. Centers for Disease Control and Prevention. Contraception. https://www.cdc.gov/reproductivehealth/contraception/index.htm#Contraceptive-Effectiveness. Updated August 13, 2020. Retrieved August 25, 2020.
  2. World Health Organization. Family planning/contraception methods. https://www.who.int/en/news-room/fact-sheets/detail/family-planning-contraception. Updated June 22, 2020. Retrieved August 25, 2020.


Related Articles

Female cancer patient receiving chemotherapy
Adoptive Immunotherapy is Being Studied in Ovarian Cancer

Trial examines novel approach for a disease with a high mortality rate

woman doing yoga
Rethinking Activity After Pelvic Prolapse Surgery

New guidelines let the patients steer the process

pregnant patient with doctor
Pregnancy and the Penicillin-Allergic Patient

Comparing strategies for cesarean prophylaxis with penicillin allergy

Medical illustration of endometriosis
Fertility Preservation for Patients with Endometriosis

Counseling and careful surgical considerations are key

woman with milk and lettuce
Neighborhood Factors Affect Early Pregnancy Metabolic Health

Deprivation is linked to impaired glucose intolerance and racial disparities

23-WHI-4386458 – OGI – CQD – topical treatment for VIN
Trial Shows Promise for Topical Treatment for VIN

Artesunate ointment is safe well and tolerated patients with vulvar intraepithelial neoplasia

Paul Bryson
November 29, 2023/Ob/Gyn & Women’s Health
New Review Indicates Airway Stenosis Treatment During Pregnancy Is Safe and Effective

Endoscopic balloon dilation during pregnancy helps optimize outcomes